Spleen Volume Reduction Is a Reliable and Independent Biomarker for Long-Term Risk of Leukopenia Development in Peptide Receptor Radionuclide Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Spleen Volume Reduction Is a Reliable and Independent Biomarker for Long-Term Risk of Leukopenia Development in Peptide Receptor Radionuclide Therapy

Published:2024-07-11 Issue:8 Volume:65 Page:1244-1249
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Steinhelfer Lisa,Jungmann Friederike,Endrös Lukas,Wenzel Patrick,Haller Bernhard,Nickel Manuel,Haneder Eva,Geisler Fabian,Götze Katharina,von Werder Alexander,Eiber Matthias,Makowski Markus R.,Braren Rickmer,Lohöfer Fabian

Publisher

Society of Nuclear Medicine

Reference32 articles.

1. Peptide receptor radionuclide therapy of neuroendocrine tumors;Bodei;Front Horm Res.,2015

2. Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate

3. ENETS consensus guidelines for the standards of care in neuroendocrine neoplasms: systemic therapy—biotherapy and novel targeted agents;Pavel;Neuroendocrinology.,2017

4. Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

5. Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP